Will multiple myeloma treatment meet a new paradigm?
As a number of products emerges – DDP-4 inhibitors, SGLT-2 inhibitors, basal insulin and GLP-1 agonists –, ‘diabetes treatment’ has met a new treatment paradigm. Emergence of various treatments has allowed patients to have personalized treatments beyond existing treatments.
Yet, another treatmen...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
